The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

Gastroenterology Clinics of North America

Volumn 38, Issue 1, 2009, Pages 105-120

  Yoon, Harry H ^a   Lowe, Val J ^a   Cassivi, Stephen D ^a   Romero, Yvonne ^a  

^a MAYO CLINIC   (United States)

Author keywords

CT; Esophageal cancer; Gastroesophageal junction cancer; PET; Prognosis; Staging; Staging laparoscopy; Treatment response

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE 6 PHOSPHATE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; HUMAN; LAPAROSCOPY; LOWER ESOPHAGUS SPHINCTER; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW;

ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROSCOPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 62749194562     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2009.01.007     Document Type: Review

References (32)

1. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 27 (1998) 1979-1984
2. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 2 (2001) 305-313
3. Lowe V.J., Booya F., Fletcher J.G., et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7 6 (2005) 422-430
4. Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 18 (2000) 3202-3210
5. Bruzzi J.F., Munden R.F., Truong M.T., et al. PET/CT of esophageal cancer: its role in clinical management. Radiographics 27 6 (2007) 1635-1652
6. Meyers B.F., Downey R.J., Decker P.A., et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133 3 (2007) 738-745
7. van Westreenen H.L., Westerterp M., Bossuyt P.M., et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22 18 (2004) 3805-3812
8. Kneist W., Schreckenberger M., Bartenstein P., et al. Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?. World J Surg 27 10 (2003) 1105-1112
9. Rice T.W. Clinical staging of esophageal carcinoma: CT, EUS, and PET. Chest Surg Clin N Am 10 3 (2000) 471-485
10. Heeren P.A., Jager P.L., Bongaerts F., et al. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 45 6 (2004) 980-987
11. Luketich J.D., Schauer P., Landreneau R., et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 114 5 (1997) 817-821 [discussion: 21-3]
12. Cerfolio R.J., Bryant A.S., Ohja B., et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129 6 (2005) 1232-1241
13. Bruzzi J.F., Swisher S.G., Truong M.T., et al. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109 1 (2007) 125-134
14. Ott K., Weber W.A., Lordick F., et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24 29 (2006) 4692-4698
15. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 9319 (2002) 1727-1733
16. Erasmus J.J., Munden R.F., Truong M.T., et al. Preoperative chemoradiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1 5 (2006) 478-486
17. Port J.L., Lee P.C., Korst R.J., et al. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 84 2 (2007) 393-400
18. 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 21 3 (2003) 428-432
19. Ribi K, Nitzsche E, Schuller J, et al. PET scanning and patient reported dysphagia before and after chemotherapy (CT) for prediction of pathological response after CT and chemoradiotherapy (CRT) in patients with locally advanced esophageal cancer (EC): a multicenter phase II trial of the Swiss. 2007 ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2007;25(June 20 Supplement):4587.
20. Gea K.U. Phase II trial of preoperative cisplatin/irinotecan and radiotherapy for locally advanced esophageal cancer: PET scan after induction therapy may identify early treatment failure. ASCO Gastrointestinal Cancers Symposium (2007). Available at: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vm view=abst_detail_view&confID=45&abstractID=10131 Accessed September 23, 2008
21. de Graaf G.W., Ayantunde A.A., Parsons S.L., et al. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 33 8 (2007) 988-992
22. Heath E.I., Kaufman H.S., Talamini M.A., et al. The role of laparoscopy in preoperative staging of esophageal cancer. Surg Endosc 14 5 (2000) 495-499
23. Kaiser G.M., Sotiropoulos G.C., Fruhauf N.R., et al. Value of staging laparoscopy for multimodal therapy planning in esophagogastric cancer. Int Surg 92 3 (2007) 128-132
24. Kaushik N., Khalid A., Brody D., et al. Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer. Ann Thorac Surg 83 6 (2007) 2000-2002
25. Krasna M.J., Jiao X., Mao Y.S., et al. Thoracoscopy/laparoscopy in the staging of esophageal cancer: Maryland experience. Surg Laparosc Endosc Percutan Tech 12 4 (2002) 213-218
26. Krasna M.J., Reed C.E., Nedzwiecki D., et al. CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. Ann Thorac Surg 71 4 (2001) 1073-1079
27. Patel A.N., and Buenaventura P.O. Current staging of esophageal carcinoma. Surg Clin North Am 85 3 (2005) 555-567
28. Wallace M.B., Nietert P.J., Earle C., et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 74 4 (2002) 1026-1032
29. Block M., Patterson G.A., Sundaresan R.S., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64 (1997) 770-777
30. Luketich J.D., Schauer P.R., Meltzer C.C., et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64 3 (1997) 765-769
31. Lordick F., Ott K., Krause B.J., et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8 9 (2007) 797-805
32. Swisher S.G., Erasmus J., Maish M., et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101 8 (2004) 1776-1785